Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Explore the inspiring stories of the Fierce 50
anti-aging drugs
Biotech
AgeX keeps defying time to survive multiyear cash crunch
AgeX continues to defy Father Time, ending yet another quarter with less than $1 million in the bank and repeating its well-worn going concern notice.
Nick Paul Taylor
Aug 15, 2023 7:00am
Optogenetic platform illuminates aging pathways in cells
Jul 19, 2023 12:58am
Time may be running out for anti-aging biotech AgeX
Aug 15, 2022 11:20am
Insilico's target discovery AI zeroes in on age-related diseases
Mar 29, 2022 3:55pm
Deleting a gene in mice helps delay age-related inflammation
Feb 15, 2022 8:55am
Korify rolls out $100M longevity and mental health venture fund
Dec 22, 2021 4:20am
